Item 9A. Controls and Procedures
Item 9A. Controls and Procedures
Evaluation of disclosure controls and procedures over financial reporting
We have established disclosure controls and procedures to ensure that material information relating to the Company is made known to the officers who certify our financial reports and to the members of our senior management and Board of Directors.
Based on management’s evaluation as of February 1, 2025, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to ensure that the information required to be disclosed by us in our reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Management’s annual report on internal control over financial reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Internal control over financial reporting is a process designed by, or under the supervision of, the principal executive officer and principal financial officer and effected by the Board of Directors, management, and other personnel, to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with U.S generally accepted accounting principles.
Under the supervision and with the participation of our principal executive officer and our principal financial officer, management evaluated the effectiveness of our internal control over financial reporting as of February 1, 2025, based on the criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO). Based on this evaluation, our principal executive officer and principal financial officer concluded that our internal controls over financial reporting were effective as of February 1, 2025. Ernst & Young LLP, the independent registered public accounting firm that audited our financial statements included in this Annual Report on Form 10-K, has audited the effectiveness of our internal control over financial reporting as of February 1, 2025 and has issued the attestation report included in Item 8 of this Annual Report on Form 10-K.
Changes in internal control over financial reporting
There were no changes to our internal controls over financial reporting during the 13 weeks ended February 1, 2025 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.
Item 9B. Other Information
During the 13 weeks ended February 1, 2025, no director or Section 16 officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K .
76
Table of Contents
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Not applicable.
Part III
Item 10. Directors, Executive Officers, and Corporate Governance
The information required by this item with respect to our executive officers is set forth in Part I, Item 4A of this Annual Report on Form 10- K under the caption “Executive Officers.” The additional information required by this item is included under the captions “Corporate Governance – Code of Business Conduct,” “Corporate Governance – Nomination Process – Qualifications,” “Corporate Governance – Proposal One – Election of Directors,” “Corporate Governance – Information About Our Director Nominees,” “Corporate Governance – Insider Trading Policy” and “Corporate Governance – Audit Committee” in our definitive Proxy Statement for our 2025 Annual Meeting of Stockholders (the Proxy Statement) and is hereby incorporated herein by reference.
We have a code of business conduct that applies to all of our employees, including our Chief Executive Officer, Chief Financial Officer, Controller, and other persons performing similar functions. We have posted a copy of our code of business conduct under “Governance” in the Investor Relations section of our website located at http://ulta.com/investor, and such code of business conduct is available in print, without charge, to any stockholder who requests it from our Corporate Secretary. We intend to satisfy the disclosure requirements under Item 5.05 of Form 8-K regarding amendments to, or waivers from, the code of business conduct by posting such information under “Governance” in the Investor Relations section of our website located at http://ulta.com/investor. We are not including the information contained on our website as part of, or incorporating it by reference into, this Annual Report on Form 10-K.
Item 11. Executive Compensation
The information required by this item is included under the captions “Compensation Discussion and Analysis,” “Corporate Governance – Compensation Committee,” “Corporate Governance – Report of the Compensation Committee of the Board of Directors,” and “Corporate Governance – Non-Employee Director Compensation for Fiscal 2024” in the Proxy Statement and is hereby incorporated herein by reference.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The information required by this item with respect to security ownership of certain beneficial owners and management is included under the caption "Stock Ownership” in the Proxy Statement and is hereby incorporated by reference. The information required by this item with respect to compensation plans under which our equity securities are authorized for issuance as of February 1, 2025 is set forth in Item 5 of this Annual Report on Form 10-K under the caption “Securities authorized for issuance under equity compensation plans.”
Item 13. Certain Relationships and Related Transactions, and Director Independence
The information required by this item is included under the captions “Corporate Governance – Independence,” “Corporate Governance – Compensation Committee – Compensation Committee Interlocks and Insider Participation,” and “Certain Relationships and Transactions” in the Proxy Statement and is hereby incorporated by reference.
Item 14. Principal Accountant Fees and Services
The information required by this item is included under the caption “Corporate Governance – Proposal Two – Ratification of Appointment of Independent Registered Public Accounting Firm – Fees to Independent Registered Public Accounting Firm” in the Proxy Statement and is hereby incorporated by reference.
77
Table of Contents
Part IV
Item 15. Exhibits and Financial Statement Schedules
(a)
Financial Statements and Schedules
The following documents are filed as a part of this Form 10-K:
Reports of Independent Registered Public Accounting Firm (PCAOB ID: 42 )
47
Consolidated Balance Sheets
51
Consolidated Statements of Income
52
Consolidated Statements of Cash Flows
53
Consolidated Statements of Stockholders’ Equity
54
Notes to Consolidated Financial Statements
55
Schedule II – Valuation and Qualifying Accounts
75
All other financial statement schedules required by Form 10-K have been omitted because they were inapplicable or otherwise not required under the instructions contained in Regulation S-X.
(b) Exhibits
The exhibits listed in the Exhibit Index below are filed as part of this Annual Report on Form 10-K.
78
Table of Contents
EXHIBIT INDEX
Incorporated by Reference
Exhibit
Filed
Exhibit
File
Number
Description of document
Herewith
Form
Number
Number
Filing Date
3.1
Certificate of Incorporation of Ulta Beauty, Inc., as amended through June 1, 2023
8-K
3.1
001-33764
6/07/2023
3.2
Bylaws of Ulta Beauty, Inc., as amended through June 1, 2023
8-K
3.3
001-33764
6/07/2023
4
Description of Ulta Beauty, Inc.’s Securities
10-K
4
001-33764
3/26/2024
10.1
Compensation Plan Agreement, dated as of January 27, 2017 between Ulta Salon, Cosmetics & Fragrance, Inc. and Ulta Beauty, Inc.*
8-K
10.1
001-33764
1/30/2017
10.2
Amendment No. 3 to Second Amended and Restated Agreement, dated March 13, 2024, among Ulta Beauty, Inc., Ulta Salon, Cosmetics & Fragrance, Inc., the subsidiaries of Ulta Beauty signatory thereto, the lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent and collateral agent for the lenders
10-K
10.2
001-33764
3/26/2024
10.3
Amended and Restated Ulta Beauty, Inc. 2011 Incentive Award Plan*
DEF 14A
Appendix A
001-33764
4/20/2016
10.4
Form of Restricted Stock Unit Award Agreement—Performance Shares under the 2011 Incentive Award Plan*
8-K
10.1
001-33764
3/31/2015
10.5
Ulta Salon, Cosmetics & Fragrance, Inc. Non-qualified Deferred Compensation Plan*
10-K
10.17
001-33764
4/2/2009
10.6
Letter Agreement dated January 6, 2014 between Ulta Inc. and David Kimbell*
10-Q
10.1
001-33764
6/4/2015
10.7
Form of Option Agreement under the 2011 Incentive Award Plan*
10-K
10.13
001-33764
3/28/2017
10.8
Form of Restricted Stock Unit Award Agreement under the 2011 Incentive Award Plan*
10-K
10.14
001-33764
3/28/2017
10.9
Letter Agreement dated August 3, 2015 between Ulta Inc. and Jodi J. Caro*
10-K
10.15
001-33764
3/28/2017
10.10
Ulta Beauty, Inc. Executive Change in Control and Severance Plan*
10-K
10.16
001-33764
3/28/2017
10.11
New Form of Restricted Stock Unit Award Agreement—PSUs—under the Amended and Restated Ulta Beauty, Inc. 2011 Incentive Award Plan*
8-K
10.1
001-33764
3/30/2021
79
Table of Contents
Incorporated by Reference
Exhibit
Filed
Exhibit
File
Number
Description of document
Herewith
Form
Number
Number
Filing Date
10.12
New Form of Stock Option Agreement under the Amended and Restated Ulta Beauty, Inc. 2011 Incentive Award Plan*
8-K
10.2
001-33764
3/30/2021
10.13
Alternative Form of Restricted Stock Unit Award Agreement—PSUs—under the Amended and Restated Ulta Beauty, Inc. 2011 Incentive Award Plan*
10-K
10.25
001-33764
3/25/2022
10.14
Alternative Form of Stock Option Agreement under the Amended and Restated Ulta Beauty, Inc. 2011 Incentive Award Plan*
10-K
10.26
001-33764
3/25/2022
10.15
Alternative Form of Restricted Stock Unit Award Agreement under the Amended and Restated Ulta Beauty, Inc. 2011 Incentive Award Plan*
10-K
10.27
001-33764
3/25/2022
10.16
2023 Form of Restricted Stock Unit Award Agreement—PSUs—under the Amended and Restated Ulta Beauty, Inc. 2011 Incentive Award Plan*
10-K
10.20
001-33764
3/24/2023
10.17
2023 Form of Stock Option Agreement under the Amended and Restated Ulta Beauty, Inc. 2011 Incentive Award Plan*
10-K
10.21
001-33764
3/24/2023
10.18
2023 Form of Restricted Stock Unit Award Agreement under the Amended and Restated Ulta Beauty, Inc. 2011 Incentive Award Plan*
10-K
10.22
001-33764
3/24/2023
10.19
Transition and Advisory Agreement between Ulta Beauty, Inc. and David Kimbell
X
19
Ulta Beauty, Inc. Insider Trading Policy
X
21
List of Significant Subsidiaries
X
23
Consent of Independent Registered Public Accounting Firm
X
31.1
Certification of the Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002
X
31.2
Certification of the Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002
X
80
Table of Contents
Incorporated by Reference
Exhibit
Filed
Exhibit
File
Number
Description of document
Herewith
Form
Number
Number
Filing Date
32.1
Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
X
32.2
Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
X
97
Ulta Beauty, Inc. Senior Leadership Clawback Policy
10-K
97
001-33764
3/26/2024
99
Proxy Statement for the 2025 Annual Meeting of Stockholders. [To be filed with the SEC under Regulation 14A within 120 days after February 1, 2025; except to the extent specifically incorporated by reference, the Proxy Statement for the 2025 Annual Meeting of Stockholders shall not be deemed to be filed with the SEC as part of this Annual Report on Form 10-K]
101.INS
Inline XBRL Instance
X
101.SCH
Inline XBRL Taxonomy Extension Schema
X
101.CAL
Inline XBRL Taxonomy Extension Calculation
X
101.LAB
Inline XBRL Taxonomy Extension Labels
X
101.PRE
Inline XBRL Taxonomy Extension Presentation
X
101.DEF
Inline XBRL Taxonomy Extension Definition
X
104
Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101).
* A management contract or compensatory plan or arrangement.
Item 16. Form 10-K Summary
None.
81
Table of Contents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Bolingbrook, State of Illinois, on March 27, 2025.
ULTA BEAUTY, INC.
By:
/s/ Paula M. Oyibo
Paula M. Oyibo
Chief Financial Officer and Treasurer
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
Signatures
Title
Date
/s/ Kecia L. Steelman
President and Chief Executive Officer
March 27, 2025
Kecia L. Steelman
and Director (Principal Executive Officer)
/s/ Paula M. Oyibo
Chief Financial Officer and Treasurer
March 27, 2025
Paula M. Oyibo
(Principal Financial and Accounting Officer)
/s/ Michelle L. Collins
Director
March 27, 2025
Michelle L. Collins
/s/ Kelly E. Garcia
Director
March 27, 2025
Kelly E. Garcia
/s/ Catherine Halligan
Director
March 27, 2025
Catherine Halligan
/s/ Patricia A. Little
Director
March 27, 2025
Patricia A. Little
/s/ Michael R. MacDonald
Director
March 27, 2025
Michael R. MacDonald
/s/ George Mrkonic
Director
March 27, 2025
George Mrkonic
/s/ Lorna E. Nagler
Non-Executive Chair of the Board of
March 27, 2025
Lorna E. Nagler
Directors
/s/ Heidi G. Petz
Director
March 27, 2025
Heidi G. Petz
/s/ Gisel Ruiz
Director
March 27, 2025
Gisel Ruiz
/s/ Michael C. Smith
Director
March 27, 2025
Michael C. Smith
82